mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |